The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9,056.00
Bid: 9,054.00
Ask: 9,062.00
Change: -48.00 (-0.53%)
Spread: 8.00 (0.088%)
Open: 9,156.00
High: 9,156.00
Low: 9,010.00
Prev. Close: 9,104.00
NXT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

3 Jan 2018 07:00

RNS Number : 7810A
Next PLC
03 January 2018
 

Date:

Embargoed until 07.00hrs, Wednesday 3 January 2018

 

 

Contacts:

Lord Wolfson, Chief Executive

 

Amanda James, Finance Director (analyst calls)

 

NEXT PLC

Tel: 0333 777 8888

 

 

 

Alistair Mackinnon-Musson

Email: next@rowbellpr.com

 

Rowbell PR

Tel: 020 7717 5239

 

 

Photographs:

http://www.nextplc.co.uk/media/image-gallery/campaign-images

 

Next plc - Trading Statement - 3 January 2018

 

SALES FOR THE YEAR TO 24 DECEMBER 2017

Full price sales in the 54 days from Wednesday 1 November to Sunday 24 December were up +1.5% on last year; an improvement on our November guidance which was -0.3%. The table below sets out the sales performance in Retail stores and Online for the Christmas trading period and the year to date. Both channels experienced an improvement in sales, with our Online business performing particularly well. We believe part of this improvement has been down to much colder weather leading up to Christmas.

 

Full Price Sales (VAT exclusive)

54 days to 24 Dec

 

Year to 24 Dec

Retail

- 6.1%

- 7.2%

Online

+13.6%

+10.4%

Brand Total

+1.5%

+ 0.2%

Of which sales from new space

1.1%

1.3%

 

The bar graph below shows the year on year full price sales variance by quarter. 

 

Click or paste the following link into your web browser to view the bar graph titled "2017 Full Price Sales Variance by Quarter vs 2016". Refer to page 1 for this graph.

http://www.rns-pdf.londonstockexchange.com/rns/7810A_-2018-1-2.pdf

End-of-Season Sale

Stock for our end-of-season Sale (including the stock we put into our Black Friday event) was well controlled and down -6% on last year. Clearance rates are in line with our expectations and are consistent with the profit guidance we gave in November.

Full Price Sales and Profit Guidance for the Current Year

Better than expected full price sales means that we are marginally upgrading our profit guidance. Our central guidance for Group profit increases by £8m to £725m and our profit guidance range is now £718m to £732m. Where we fall within this range will depend on our sales in January. 

The table below sets out our latest central guidance for the full year to January 2018.

Full Year Estimate

New Central Guidance

Previous Central Guidance

Year to January 2018 (52 week basis)

Total full price sales versus 2016/17 (inc currency gain)

+0.3%

- 0.3%

Group profit before tax

£725m

£717m

Group profit before tax versus 2016/17

- 8.3%

- 9.3%

Earnings Per Share growth versus 2016/17

- 5.7%

- 6.8%

 

OUTLOOK FOR SALES, PROFIT, CASH FLOW AND EPS IN THE YEAR AHEAD

Sales

Many of the challenges we faced last year look set to continue into the year ahead. Subdued consumer demand driven by a decline in real income, the increase in experiential spending at the expense of clothing, and inflation in our cost prices remain challenges for 2018. However, we believe that some of these headwinds will ease as we move through the year; we already know that cost price inflation will reduce to 2% in the first half and believe it will disappear in the second half. 

We are budgeting for full price sales next year to grow by between -2% and +4%. The mid-point of +1% represents a modest improvement on this year's anticipated growth of +0.3%. 

Profit

It is very early to be issuing profit guidance for the year ahead, but if sales do grow at +1% we estimate that Group profit would be around £705m. This is marginally down on the current year as we expect operational costs to continue to grow faster than sales.

Cash Flow and EPS

We estimate that at our central guidance of £705m Group profit we will generate around £300m of surplus cash. Surplus cash is cash flow after capital expenditure, interest, tax and ordinary dividends but before financing any increase in Directory debtors (which we would fund through long-term bonds and bank facilities). It is our intention to distribute this surplus cash to shareholders by way of share buybacks, subject to market conditions. As at 1 January's share price of £45.25 a £300m buyback would retire 4.7% of the Company's share capital and on a full year basis boost Earnings Per Share by a similar amount. We will see some of this enhancement in the year ahead and at our central guidance, Earnings Per Share would move forward by +1.1%.

Our central guidance for sales, profits and Earnings Per Share is set out in the table below.

Full Year Estimate

Central

Guidance

Year to January 2019 (52 week basis)

Total full price sales versus 2017/18

+1.0%

Group profit before tax

£705m

Group profit before tax versus 2017/18

- 2.8%

Earnings Per Share growth versus 2017/18

+1.1%

We are scheduled to announce our results for the full year on Friday 23 March 2018, when we will give more detailed guidance on sales, costs, profit and cash flow for the year ahead.

 

Forward Looking Statements

Certain statements in this Trading Update are forward looking statements. These statements may contain the words "anticipate", "believe", "intend", "aim", "expects", "will", or words of similar meaning. By their nature, forward looking statements involve risks, uncertainties or assumptions that could cause actual results or events to differ materially from those expressed or implied by those statements. As such, undue reliance should not be placed on forward looking statements. Except as required by applicable law or regulation, NEXT plc disclaims any obligation or undertaking to update these statements to reflect events occurring after the date these statements were published.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLLLBVFFFBBE
Date   Source Headline
23rd Apr 20244:31 pmRNSHolding(s) in Company
12th Apr 20242:16 pmRNSAnnual Financial Report
8th Apr 20244:43 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
26th Mar 20249:50 amRNSHolding(s) in Company
22nd Mar 20242:26 pmRNSDirector/PDMR Shareholding
22nd Mar 20242:24 pmRNSDirector/PDMR Shareholding
22nd Mar 20249:15 amRNSDirector Declaration
21st Mar 20241:15 pmRNSDirector Declaration
21st Mar 202412:50 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSNEXT plc Results for the Year Ended January 2024
1st Mar 20249:00 amRNSTotal Voting Rights
19th Feb 20242:27 pmRNSClosed Period Share Repurchase Programme
15th Feb 20244:58 pmRNSTransaction in Own Shares
6th Feb 20245:12 pmRNSTransaction in Own Shares
2nd Feb 20245:10 pmRNSTransaction in Own Shares
1st Feb 20245:20 pmRNSTransaction in Own Shares
1st Feb 20248:00 amRNSTotal Voting Rights
23rd Jan 20245:17 pmRNSTransaction in Own Shares
23rd Jan 20242:44 pmRNSDirector Appointment
22nd Jan 20245:41 pmRNSTransaction in Own Shares
17th Jan 20243:48 pmRNSDirector/PDMR Shareholding - Replacement
17th Jan 202412:00 pmRNSDirector Appointment
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
4th Jan 20247:00 amRNSTrading Statement
2nd Jan 20248:00 amRNSTotal Voting Rights
19th Dec 20234:45 pmRNSHolding(s) in Company
4th Dec 202310:45 amRNSDirector/PDMR Shareholding
4th Dec 202310:34 amRNSDirector/PDMR Shareholding
1st Dec 20238:00 amRNSTotal Voting Rights
14th Nov 20234:57 pmRNSHolding(s) in Company
13th Nov 202312:30 pmRNSAGM Update
1st Nov 20238:00 amRNSTotal Voting Rights
1st Nov 20237:00 amRNSTrading Statement
19th Oct 20234:00 pmRNSDirector/PDMR Shareholding
18th Oct 20233:00 pmRNSNew Issue and Additional Listing
13th Oct 20233:11 pmRNSAcquisition of FatFace
3rd Oct 20233:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:00 pmRNSBoard Changes
2nd Oct 20238:30 amRNSTotal Voting Rights
25th Sep 20235:15 pmRNSDirector/PDMR Shareholding
25th Sep 20235:09 pmRNSDirector/PDMR Shareholding
22nd Sep 20234:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSResults for the Half Year Ending July 2023
1st Sep 202312:00 pmRNSTotal Voting Rights
1st Sep 20239:30 amRNSAcquisition of Warburg Pincus’ Interest in Reiss
4th Aug 20234:07 pmRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSTrading Statement
1st Aug 20238:34 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.